Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 3;64(13):40.
doi: 10.1167/iovs.64.13.40.

Gene Expression Within a Human Choroidal Neovascular Membrane Using Spatial Transcriptomics

Affiliations

Gene Expression Within a Human Choroidal Neovascular Membrane Using Spatial Transcriptomics

Andrew P Voigt et al. Invest Ophthalmol Vis Sci. .

Abstract

Purpose: Macular neovascularization is a relatively common and potentially visually devastating complication of age-related macular degeneration. In macular neovascularization, pathologic angiogenesis can originate from either the choroid or the retina, but we have limited understanding of how different cell types become dysregulated in this dynamic process.

Methods: To study how gene expression is altered in focal areas of pathology, we performed spatial RNA sequencing on a human donor eye with macular neovascularization as well as a healthy control donor. We performed differential expression to identify genes enriched within the area of macular neovascularization and used deconvolution algorithms to predict the originating cell type of these dysregulated genes.

Results: Within the area of neovascularization, endothelial cells demonstrated increased expression of genes related to Rho family GTPase signaling and integrin signaling. Likewise, VEGF and TGFB1 were identified as potential upstream regulators that could drive the observed gene expression changes produced by endothelial and retinal pigment epithelium cells in the macular neovascularization donor. These spatial gene expression profiles were compared to previous single-cell gene expression experiments in human age-related macular degeneration as well as a model of laser-induced neovascularization in mice. As a secondary aim, we investigated regional gene expression patterns within the macular neural retina and between the macular and peripheral choroid.

Conclusions: Overall, this study spatially analyzes gene expression across the retina, retinal pigment epithelium, and choroid in health and describes a set of candidate molecules that become dysregulated in macular neovascularization.

PubMed Disclaimer

Conflict of interest statement

Disclosure: A.P. Voigt, None; N.K. Mullin, None; E.M. Navratil, None; M.J. Flamme-Wiese, None; L.-C. Lin, None; T.E. Scheetz, None; I.C. Han, None; E.M. Stone, None; B.A. Tucker, None; R.F. Mullins, None

Figures

Figure 1.
Figure 1.
Gross, clinical , and histological characterization of eyes used for spatial transcriptomic experiments. Gross photos from the control (A) and MNV (B) donor after dissection. (A) The 4-mm punch was acquired centered on the fovea and approximately 12 mm superotemporal to the macula. Whereas the macula of the healthy control donor appeared grossly normal (A), the MNV donor macula (B) demonstrated a disc-diameter area of elevated yellow material and atrophy. Near infrared scan (C) and optimal coherence tomography scan (D) of the right eye from the patient with macular neovascularization showing a broad, low-lying fibrovascular pigment epithelial detachment with “double-layer sign” (arrowhead). Reticular pseudodrusen (dark rounded profiles on near infrared scan) were noted superior to the lesion along the arcade vessels. Histological macular tissue sections from the control (E) and MNV (F) donor stained with hematoxylin and eosin. Note the thinning of the outer nuclear layer and fibrovascular membrane in the MNV eye. ONL, outer nuclear layer; IS, inner segments; OS, outer segments; NVM, neovascular membrane; BrM, Bruch's membrane; CHO, choroid.
Figure 2.
Figure 2.
Spatial RNA sequencing of a control and MNV human donor macula. (A) Experimental overview: tissue sections from a control donor (n = 2 sections) and an MNV donor (n = 3 sections) were prepared for spatial RNA sequencing. After fixation and imaging, sections were permeabilized and cDNA libraries were prepared. Hematoxylin and eosin staining of one section of the control donor (B). The RNA contribution from retinal, RPE, and choroidal cell types was estimated in each spatially barcoded spot (C) and displayed as a pie-chart. Panels (D) and (E) show a magnified view of the spot area in the macular (top) and peripheral (bottom) sections. Spots overlying the sclera were excluded from this visualization. (F) Uniform manifold approximation and projection (UMAP) dimensionality reduction was applied to visualize clusters of spots with similar gene expression profiles. Each point represents the multidimensional transcriptomic profile from one spot, and points are colored according to the maximally predicted RNA contribution in each spatially barcoded spot. Clustering was visualized according to region (G), tissue (H), and percentage of the spot area that overlaps with the MNV membrane (I).
Figure 3.
Figure 3.
Gene expression in a human macular neovascular membrane. (A, B, C) The three macular sections from the MNV donor. The neovascular membrane (red outline) is traced in each tissue section and overlapping spot areas (black circles) are visualized. Note that the neovascular membrane spanned the entire section in each case. (D) The percent area that each spot overlapped the MNV membrane was calculated. A total of 144 spots overlapped the lesion, ranging from <1% to 91% overlap. (E) For all spots overlapping the MNV, the relative cell type composition was calculated. (F) Design of differential expression analysis. Cell type deconvolution and percent area overlap with the MNV were used as covariates for differential expression analysis. (G, H, I, J) After identifying genes enriched in MNV spots, ingenuity pathway analysis was used to identify canonical pathways (G, H) and upstream regulators (I, J) of genes predicted to originate from endothelial cells and RPE cells.
Figure 4.
Figure 4.
(A) Comparison of MNV-enriched genes in endothelial cells with previous single-cell RNA sequencing studies. Genes upregulated and downregulated in MNV-associated spots according to spatial RNA sequencing (green, current study) were compared to a previous single-cell RNA sequencing study of two human donors with MNV (blue) and a mouse model of choroidal neovascularization (red). Positive log2 fold-changes are associated with increased expression in the neovascular endothelial cells. (B) Differential expression between macular and peripheral enriched genes in choroidal endothelial cells. Cell type deconvolution and region were used as covariates for differential expression analysis. For endothelial cells, the top differentially expressed genes between the macula and periphery were identified from a previous single-cell RNA sequencing study. Differential expression results were compared between this previous study (purple) and the current spatial study (gold). Positive log2 fold-changes are associated with increased expression in the macula.
Figure 5.
Figure 5.
Comparison of regional retinal gene expression differences between spatial and single-cell RNA sequencing studies. Differential expression was completed to compare genes enriched toward the center and towards the periphery of each section. For macular sections, the distance between each spot and the center of the slide was calculated and scaled from 0 to 1. Cell type deconvolution and distance from the center were used as covariates for differential expression analysis. For cone photoreceptor cells (A) and Muller cells (B), the top differentially expressed genes between the fovea and parafovea were identified from a previous single-cell RNA sequencing study. Differential expression results were compared between this previous study (red) and the current spatial study (blue). Positive log2 fold-changes are associated with increased expression toward the center of the retina.
Figure 6.
Figure 6.
Immunohistochemical detection of TIMP3 (A, D) and NNMT (B, E) in an eye with a multilayered MNV membrane with subretinal fibrosis separated by a confluent layer of basal laminar deposit (BlamD). Abundant Bruch's membrane (BrM) TIMP3 is present outside of the area of MNV (A), whereas within the neovascular lesion on the same section there is strong labeling in the BlamD but the signal is attenuated in BrM (D). Labeling with anti-NNMT antibodies (B, E) shows little reactivity outside of the neovascular lesion (B) but intense binding to elongated cells throughout the MNV membrane (E). Panels (C) and (F) show three channel merged images. GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; CHO, choroid. Scalebar = 100 µm.

Update of

References

    1. Spaide RF, Jaffe GJ, Sarraf D, et al. .. Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group. Ophthalmology. 2020; 127: 616–636. PMID 31864668. - PMC - PubMed
    1. Laiginhas R, Yang J, Rosenfeld PJ, Falcão M. Nonexudative macular neovascularization - a systematic review of prevalence, natural history, and recent insights from OCT angiography. Ophthalmol Retina. 2020; 4: 651–661. PMID 32335033. - PMC - PubMed
    1. Khanna S, Komati R, Eichenbaum DA, Hariprasad I, Ciulla TA, Hariprasad SM. Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review. BMJ Open Ophthalmol. 2019; 4: e000398. PMID 31909196. - PMC - PubMed
    1. Golbaz I, Ahlers C, Stock G, et al. . Quantification of the therapeutic response of intraretinal, subretinal, and subpigment epithelial compartments in exudative AMD during anti-VEGF therapy. Invest Ophthalmol Vis Sci. 2011; 52: 1599–1605. PMID 21051733. - PubMed
    1. Keane PA, Liakopoulos S, Ongchin SC, et al. . Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008; 49: 3115–3120. PMID 18408176. - PMC - PubMed

Publication types